Verkazia (cyclosporine 0.1% ophthalmic emulsion) — Medica

Initial criteria

• Patient is age ≥ 4 years; AND
• According to the prescriber, the patient has moderate to severe vernal keratoconjunctivitis; AND
• Patient meets ONE of the following:
• - Patient has tried two single-action ophthalmic medications (ophthalmic mast cell stabilizers or ophthalmic antihistamines) for the maintenance treatment of vernal keratoconjunctivitis; OR
• - Patient has tried one dual-action ophthalmic mast-cell stabilizer/antihistamine product for the maintenance treatment of vernal keratoconjunctivitis; AND
• An exception to the above requirement can be made if the patient has already tried at least one ophthalmic cyclosporine product (e.g., Cequa, Restasis, Vevye) other than the requested medication; AND
• Medication is prescribed by or in consultation with an optometrist or ophthalmologist.

Approval duration

1 year